Name/Company | Approval Dates and Comments |
Alitretinion | The health authorities in Austria, Belgium, |
Pralatrexate | The US FDA received a New Drug Application |
Benzyl Alcohol Lotion 5% | The US FDA approved this new prescription |
Botulinum Toxin – Type A | The Danish Medicines Agency (DKMA) approved this once-daily oral treatment in September 2008 for the treatment of adults with severe chronic hand eczema that is unresponsive to potent topical corticosteroids. Marketing applications for this product are also under review in Canada and Switzerland. |
Drug News |
The Genentech unit of Roche Holding AG reported in April 2009, that it is pulling |
Health Canada and Allergan are informing healthcare professionals about important safety information related to botulinum toxin – type A and the potential risk of serious adverse effects of muscle weakness remote to the injection site. Key safety updates within the new product monographs for this neurotoxin include:
Any case of serious suspected distant toxin spread or other serious or unexpected |